$34.20
Today
as of Jul 22, 16:54 ET
Last 30 days
Recent Press Releases & News
Septerna's Chief People Officer Sold Nearly 12,000 Company Shares. What Does That Mean for Investors?
Is Septerna, Inc. (SEPN) Stock a Biotech Opportunity With a Potential First-in-Class Hypoparathyroidism Treatment?
Is Septerna a Stock to Sell After an Insider Let Go of 15,000 Shares?
Overview
52-week range
$9.70
$33
100% of range
Avg surprise (last 3)
-328.7%
Avg reaction (last 2)
-0.8%
0% positive
Latest IV / EM
83%
EM ±19.1% · $34 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Mon May 11, 2026 | Mar/2026 | $-0.19 | $-0.51 | +62.8% | +61.2% | -1.3% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $0.18 | — | — | — | — | financials |
| Mon Aug 11, 2025 | Jun/2025 | $-0.56 | $-0.05 | -1,020% | — | — | earnings |
| Thu May 15, 2025 | Mar/2025 | $-0.49 | $-0.38 | -28.9% | — | -0.4% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-8.40 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-7.03 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-6.35 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-5.45 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Mon Aug 10, 2026 | Jun/2026 | OTHER | -$0.48 | -$0.56 | +14.3% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $27M | — | $21M | $119,000 | $219,000 | — | $176,000 | $370,000 |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-13M | — | $3M | $-29M | $-26M | — | $-23M | $-18M |
| Net income | $-9M | — | $8M | $-25M | $-21M | — | $-21M | $-17M |
| EPS (diluted) | $-0.19 | — | $0.18 | $-0.56 | $-0.49 | — | $-8.40 | $-7.03 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $72M | $121M | $320M | $189M | $210M | $238M | $88M | $131M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $368M | $411M | $492M | $334M | $342M | $357M | $133M | — |
| Total assets | $570M | $596M | $607M | $415M | $434M | $457M | $174M | — |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $191M | $214M | $218M | $38M | $34M | $37M | $38M | — |
| Total equity | $378M | $382M | $389M | $378M | $-400M | $420M | $-87M | $-68M |